In HCC-1954, 5-aza-dC treatment reactivated both LBH and VGLL3 expression, and TGF-β treatment further induced LBH, but not VGLL3 (Figures 5C, 5D, and S4E). This evidence concerns the gene VGLL3 and hepatocellular carcinoma.